Viking Therapeutics VKTX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's interest coverage?
- Viking Therapeutics (VKTX) reported interest coverage of -16.9× in Q1 2026.
- How has Viking Therapeutics's interest coverage changed year-over-year?
- Viking Therapeutics's interest coverage decreased by 333.0% year-over-year, from -3.9× to -16.9×.
- What is the long-term trend for Viking Therapeutics's interest coverage?
- Over 5 years (2020 to 2025), Viking Therapeutics's interest coverage has grown at a -2.4% compound annual growth rate (CAGR), from -13.2× to -11.7×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.